A study revealed that by inhibiting Ptpn1 expression and promoting phosphorylation of insulin receptor, microRNA-206 impaired hepatic lipogenesis and exerted the beneficial effect of preventing hepatic steatosis (63). Here, PTPN1 is linked to fatty liver disease.